347 related articles for article (PubMed ID: 33216879)
21. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
22. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
23. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
24. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M; Tocci G
Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
[TBL] [Abstract][Full Text] [Related]
25. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker.
Egan BM
J Clin Hypertens (Greenwich); 2007 Oct; 9(10):783-9. PubMed ID: 17917506
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
Agrawal R; Marx A; Haller H
J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
[TBL] [Abstract][Full Text] [Related]
30. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
[TBL] [Abstract][Full Text] [Related]
31. Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study.
Asayama K; Ohkubo T; Hanazawa T; Watabe D; Hosaka M; Satoh M; Yasui D; Staessen JA; Imai Y;
J Am Heart Assoc; 2016 Mar; 5(3):e002995. PubMed ID: 27009620
[TBL] [Abstract][Full Text] [Related]
32. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study.
Neldam S; Edwards C;
Am J Geriatr Cardiol; 2006; 15(3):151-60. PubMed ID: 16687967
[TBL] [Abstract][Full Text] [Related]
33. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists.
Weir MR; Rosenberger C; Fink JC
Am J Hypertens; 2001 Sep; 14(9 Pt 1):963-8. PubMed ID: 11587165
[TBL] [Abstract][Full Text] [Related]
34. Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.
Toto RD; Tian M; Fakouhi K; Champion A; Bacher P
J Clin Hypertens (Greenwich); 2008 Oct; 10(10):761-9. PubMed ID: 19090877
[TBL] [Abstract][Full Text] [Related]
35. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
36. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
37. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
Destro M; Crikelair N; Yen J; Glazer R
Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
[TBL] [Abstract][Full Text] [Related]
39. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
Bramlage P
Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
[TBL] [Abstract][Full Text] [Related]
40. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
